{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:45:56Z","timestamp":1787499956777,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14851-0","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:36:02Z","timestamp":1759228562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early treatment-related morbidity and mortality of children with non-Hodgkin\u2019s lymphoma treated at Tikur Anbesa Specialized Hospital with modified ALCL protocol: prospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Mulualeme","family":"Nigusie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haileyesus","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Weitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Kassahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkadir","family":"Gidey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gashaw","family":"Arega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getasew","family":"Fikad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tigist","family":"Chalachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Broas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziza","family":"Shad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas Alemayehu","family":"Zewde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menberu Moges","family":"Ayele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"14851_CR1","unstructured":"National Cancer Institute. Childhood hodgkin lymphoma treatment (PDQ) health professional version. Natl Institutes Heal. Published Online 2021:1\u20139. http:\/\/www.cancer.gov\/cancertopics\/pdq\/treatment\/childhodgkins\/HealthProfessional\/page1#Section_615."},{"key":"14851_CR2","unstructured":"Pizzo PA. PDG. Malignant non-Hodgkin lymphomas in children. Princ Pract Pediatr Oncol Pediatr Oncol. 2010;OL24423569M:663\u201382."},{"issue":"7","key":"14851_CR3","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/pbc.24194","volume":"59","author":"P Aka","year":"2012","unstructured":"Aka P, Kawira E, Masalu N, et al. Incidence and trends in Burkitt lymphoma in Northern Tanzania from 2000 to 2009. Pediatr Blood Cancer. 2012;59(7):1234\u20138. https:\/\/doi.org\/10.1002\/pbc.24194.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"14851_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/leu.2010.245","volume":"25","author":"B Burkhardt","year":"2011","unstructured":"Burkhardt B, Oschlies I, Klapper W, et al. Non-Hodgkin\u2019s lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols. Leukemia. 2011;25(1):153\u201360. https:\/\/doi.org\/10.1038\/leu.2010.245.","journal-title":"Leukemia"},{"issue":"4","key":"14851_CR5","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/bjh.14030","volume":"173","author":"TG Gross","year":"2016","unstructured":"Gross TG, Biondi A. Paediatric non-Hodgkin lymphoma in low- and middle-income countries. Br J Haematol. 2016;173(4):651\u20134. https:\/\/doi.org\/10.1111\/bjh.14030. Epub 2016 Apr 20. PMID: 27098084; PMCID: PMC4862913.","journal-title":"Br J Haematol"},{"issue":"7","key":"14851_CR6","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1182\/blood-2006-07-036665","volume":"109","author":"MS Cairo","year":"2007","unstructured":"Cairo MS, Gerrard M, Sposto R, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood. 2007;109(7):2736\u201343. https:\/\/doi.org\/10.1182\/blood-2006-07-036665.","journal-title":"Blood"},{"issue":"4","key":"14851_CR7","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.rcl.2016.03.004","volume":"54","author":"EM Chung","year":"2016","unstructured":"Chung EM, Pavio M. Pediatric extranodal lymphoma. Radiol Clin North Am. 2016;54(4):727\u201346. https:\/\/doi.org\/10.1016\/j.rcl.2016.03.004.","journal-title":"Radiol Clin North Am"},{"issue":"6","key":"14851_CR8","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/bjh.15785","volume":"185","author":"G Chantada","year":"2019","unstructured":"Chantada G, Lam CG, Howard SC. Optimizing outcomes for children with non-Hodgkin lymphoma in low- and middle-income countries by early correct diagnosis, reducing toxic death and preventing abandonment. Br J Haematol. 2019;185(6):1125\u201335. https:\/\/doi.org\/10.1111\/bjh.15785.","journal-title":"Br J Haematol"},{"issue":"4","key":"14851_CR9","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1200\/JCO.2010.33.3369","volume":"30","author":"MS Cairo","year":"2012","unstructured":"Cairo MS, Sposto R, Gerrard M, et al. Advanced stage, increased lactate dehydrogenase, and primary site, but not adolescent age (\u2265\u200915 years), are associated with an increased risk of treatment failure in children and adolescents with mature B-cell non-Hodgkin\u2019s lymphoma: results of the FAB LM. J Clin Oncol. 2012;30(4):387\u201393. https:\/\/doi.org\/10.1200\/JCO.2010.33.3369.","journal-title":"J Clin Oncol"},{"issue":"2","key":"14851_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","volume":"13","author":"A Reiter","year":"1995","unstructured":"Reiter A, Schrappe M, Parwaresch R, et al. Non-Hodgkin\u2019s lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - A report of the Berlin-Frankfurt-M\u00fcnster group. J Clin Oncol. 1995;13(2):359\u201372. https:\/\/doi.org\/10.1200\/JCO.1995.13.2.359.","journal-title":"J Clin Oncol"},{"issue":"1","key":"14851_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","volume":"131","author":"B Burkhardt","year":"2005","unstructured":"Burkhardt B, Zimmermann M, Oschlies I, et al. The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. Br J Haematol. 2005;131(1):39\u201349. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05735.x.","journal-title":"Br J Haematol"},{"issue":"2","key":"14851_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1055\/s-2008-1066072","volume":"4","author":"A Reiter","year":"1994","unstructured":"Reiter A, Zimmermann W, Zimmermann M, von Schweinitz D, Riehm H, Mildenberger H. The role of initial laparotomy and Second-Look surgery in the treatment of abdominal B-Cell Non-Hodgkin\u2019s lymphoma of childhood. A report of the BFM group. Eur J Pediatr Surg. 1994;4(2):74\u201381. https:\/\/doi.org\/10.1055\/s-2008-1066072.","journal-title":"Eur J Pediatr Surg"},{"issue":"8","key":"14851_CR13","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1182\/blood-2007-08-106021","volume":"111","author":"EC Bluhm","year":"2008","unstructured":"Bluhm EC, Ronckers C, Hayashi RJ, et al. Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: A report from the childhood cancer survivor study. Blood. 2008;111(8):4014\u201321. https:\/\/doi.org\/10.1182\/blood-2007-08-106021.","journal-title":"Blood"},{"issue":"1","key":"14851_CR14","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1056\/nejm198303103081003","volume":"17","author":"YH Zhang","year":"2008","unstructured":"Zhang YH. Childhood non-Hodgkin lymphoma. J Leuk Lymphoma. 2008;17(1):4\u20135. https:\/\/doi.org\/10.1056\/nejm198303103081003.","journal-title":"J Leuk Lymphoma"},{"key":"14851_CR15","doi-asserted-by":"crossref","unstructured":"Magrath IT. African Burkitt\u2019s lymphoma. History, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol. 1991;13(2):222\u201346.PMID: 2069232.","DOI":"10.1097\/00043426-199122000-00019"},{"issue":"6","key":"14851_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajh.23187","volume":"87","author":"SM Mbulaiteye","year":"2012","unstructured":"Mbulaiteye SM, Anderson WF, Ferlay J, et al. Pediatric, elderly, and emerging adult-onset peaks in burkitt\u2019s lymphoma incidence were diagnosed in four continents, excluding Africa. Am J Hematol. 2012;87(6):573\u20138. https:\/\/doi.org\/10.1002\/ajh.23187.","journal-title":"Am J Hematol"},{"issue":"0","key":"14851_CR17","doi-asserted-by":"publisher","first-page":"0","DOI":"10.21608\/zumj.2019.17056.1525","volume":"0","author":"Z TURKI","year":"2019","unstructured":"TURKI Z, Ibrahim E, Abdelaziz L, Hafez B. Epidemiological characteristics of Non-Hodgkin lymphoma in clinical oncology and nuclear medicine department in Zagazig university hospitals (2013\u20132017). Zagazig Univ Med J. 2019;0(0):0\u20130. https:\/\/doi.org\/10.21608\/zumj.2019.17056.1525.","journal-title":"Zagazig Univ Med J"},{"issue":"5","key":"14851_CR18","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/1097-0142(19910301)67:5<1389::AID-CNCR2820670519>3.0.CO;2-Q","volume":"67","author":"MG Conlan","year":"1991","unstructured":"Conlan MG, Armitage JO, Bast M, Weisenburger DD. Clinical significance of hematologic parameters in non-Hodgkin\u2019s lymphoma at diagnosis. Cancer. 1991;67(5):1389\u201395. https:\/\/doi.org\/10.1002\/1097-0142(19910301)67:5%3C;1389::AID-CNCR2820670519%3E;3.0.CO;2-Q.","journal-title":"Cancer"},{"issue":"1","key":"14851_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4447-1","volume":"12","author":"N Alyahya","year":"2019","unstructured":"Alyahya N, Adiga B, Alwadei A, Alshahrani G, Alyahya F. The clinico-pathological profile of non-Hodgkin\u2019s lymphoma in Aseer region of Saudi Arabia. BMC Res Notes. 2019;12(1):1\u20137. https:\/\/doi.org\/10.1186\/s13104-019-4447-1.","journal-title":"BMC Res Notes"},{"issue":"10","key":"14851_CR20","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3324\/haematol.2016.148809","volume":"101","author":"AM Perry","year":"2016","unstructured":"Perry AM, Diebold J, Nathwani BN, MacLennan KA, M\u00fcller-Hermelink HK, Bast M, et al. Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the international Non-Hodgkin lymphoma classification project. Haematologica. 2016;101(10):1244\u201350.","journal-title":"Haematologica"},{"issue":"1","key":"14851_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5045\/br.2021.2021164","volume":"57","author":"W Jeon","year":"2022","unstructured":"Jeon W, Koh YK, Kang S, Kim H, Koh KN, Im HJ. Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis. Blood Res. 2022;57(1):41\u201350. https:\/\/doi.org\/10.5045\/br.2021.2021164.","journal-title":"Blood Res"},{"issue":"01","key":"14851_CR22","doi-asserted-by":"publisher","first-page":"017","DOI":"10.4103\/jlp.jlp_9_17","volume":"10","author":"S Sultan","year":"2018","unstructured":"Sultan S, Baloch N, Ahmed ZA, Irfan SM, Parveen S. Pattern of bone marrow involvement in Non hodgkin\u2019s lymphoma classified according to WHO classification: report of a developing country Pakistan. J Lab Physicians. 2018;10(01):017\u201320. https:\/\/doi.org\/10.4103\/jlp.jlp_9_17.","journal-title":"J Lab Physicians"},{"issue":"1","key":"14851_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/ijmpo.ijmpo_70_18","volume":"40","author":"JP Meena","year":"2019","unstructured":"Meena JP, Gupta AK, Parihar M, Seth R. Clinical profile and outcomes of Non-Hodgkin\u2019s lymphoma in children: A report from a tertiary care hospital from India. Indian J Med Paediatr Oncol. 2019;40(1):41\u20137. https:\/\/doi.org\/10.4103\/ijmpo.ijmpo_70_18.","journal-title":"Indian J Med Paediatr Oncol"},{"key":"14851_CR24","doi-asserted-by":"publisher","unstructured":"Med A. Malnutrition in childhood lymphoblastic leukemia: a predictor of early mortality during the induction-to-remission phase of the treatment. Arch Med Res. 1999;30(1):11\u20132.\u00a0https:\/\/doi.org\/10.1016\/S0188-0128(98)00026-8.","DOI":"10.1016\/S0188-0128(98)00026-8"},{"issue":"16","key":"14851_CR25","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1200\/JCO.2007.15.017","volume":"26","author":"B Coiffier","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor Lysis syndrome: an evidence-based review. J Clin Oncol. 2008;26(16):2767\u201378. https:\/\/doi.org\/10.1200\/JCO.2007.15.017.","journal-title":"J Clin Oncol"},{"issue":"4","key":"14851_CR26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/QAI.0b013e31820c011a","volume":"56","author":"MH Bateganya","year":"2011","unstructured":"Bateganya MH, Stanaway J, Brentlinger PE, et al. Predictors of survival after a diagnosis of non-Hodgkin lymphoma in a resource-limited setting: A retrospective study on the impact of HIV infection and its treatment. J Acquir Immune Defic Syndr. 2011;56(4):312\u20139. https:\/\/doi.org\/10.1097\/QAI.0b013e31820c011a.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"14851_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5586-4","volume":"19","author":"K Antel","year":"2019","unstructured":"Antel K, Levetan C, Mohamed Z, et al. The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting. BMC Cancer. 2019;19(1):1\u201311. https:\/\/doi.org\/10.1186\/s12885-019-5586-4.","journal-title":"BMC Cancer"},{"issue":"1","key":"14851_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.29271\/jcpsp.2018.01.48","volume":"28","author":"M Faizan","year":"2018","unstructured":"Faizan M, Anwar S, Khan S. Demographics and outcome in paediatric non-Hodgkin lymphoma: single centre experience at the children hospital, lahore, Pakistan. J Coll Physicians Surg Pakistan. 2018;28(1):48\u201351. https:\/\/doi.org\/10.29271\/jcpsp.2018.01.48.","journal-title":"J Coll Physicians Surg Pakistan"},{"issue":"2","key":"14851_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.phoj.2022.03.180","volume":"7","author":"AK Mishra","year":"2022","unstructured":"Mishra AK, Krishnan S, Bhattacharyya A, et al. High treatment related mortality due to infection remains a major challenge in the management of high-grade B-cell Non-Hodgkin lymphoma in children in developing countries: experience from a tertiary cancer center in Eastern India. Pediatr Hematol Oncol J. 2022;7(2):54\u201360. https:\/\/doi.org\/10.1016\/j.phoj.2022.03.180.","journal-title":"Pediatr Hematol Oncol J"},{"issue":"10","key":"14851_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/pbc.28624","volume":"67","author":"CL Pennella","year":"2020","unstructured":"Pennella CL, Deu MA, Rossi JG, et al. No benefit of interfant protocols compared to BFM-based protocols for infants with acute lymphoblastic leukemia. Results from an institution in Argentina. Pediatr Blood Cancer. 2020;67(10):30\u20131. https:\/\/doi.org\/10.1002\/pbc.28624.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"14851_CR31","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/MPH.0000000000000653","volume":"38","author":"K Jabeen","year":"2016","unstructured":"Jabeen K, Ashraf MS, Iftikhar S, Belgaumi AF. The impact of socioeconomic factors on the outcome of childhood acute lymphoblastic leukemia (ALL) treatment in a low\/middle income country(LMIC). J Pediatr Hematol Oncol. 2016;38(8):587\u201396. https:\/\/doi.org\/10.1097\/MPH.0000000000000653.","journal-title":"J Pediatr Hematol Oncol."},{"issue":"1","key":"14851_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4103\/0971-5851.177013","volume":"37","author":"RS Arigela","year":"2016","unstructured":"Arigela RS, Gundeti S, Ganta RR, Nasaka S, Linga VG, Maddali LS. Trends in management of acute lymphoblastic leukemia: influence of insurance based healthcare and treatment compliance on the outcome of adolescents and adults with acute lymphoblastic leukemia. Indian J Med Paediatr Oncol. 2016;37(1):32\u20137. https:\/\/doi.org\/10.4103\/0971-5851.177013.","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"1","key":"14851_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjpo-2017-000149","volume":"1","author":"HA Martijn","year":"2017","unstructured":"Martijn HA, Njuguna F, Olbara G, et al. Influence of health insurance status on paediatric non-Hodgkin\u2019s lymphoma treatment in Kenya. BMJ Paediatr Open. 2017;1(1):1\u201313. https:\/\/doi.org\/10.1136\/bmjpo-2017-000149.","journal-title":"BMJ Paediatr Open"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14851-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14851-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14851-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:29:55Z","timestamp":1759274995000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14851-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14851"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14851-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for the present study was obtained from the Research and Publication Committee of the Pediatrics and Child Health Department (DRCP), School of Medicine, College of Health Sciences, Addis Ababa University, and the College Institutional Review Board (IRB). The requirement for informed consent was waived because of the anonymous nature of the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"1446"}}